Company / Net Income
ResMed Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$1.4B
FY2025
5-year range
$474.5M / $1.4B
FY2021-FY2025
Trend
+37.2%
vs FY2024
Sector context
#18 of 158
Health Care
What the data says
ResMed's net income of $1.4B is higher than 89% of companies in the Health Care sector (FY2025). Net Income has increased for 4 consecutive years, from $475M in FY2021 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +17.6%. Top quartile in the Health Care sector.
Improved from $898M to $1.4B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +17.6%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 158This company $1.4B Sector average $458.6M
▼
+205.4% above sector average
Key checks
Key Insights
- ResMed's net income has grown for 4 consecutive years.
- 5-year CAGR of +17.6%, indicating consistent growth.
- In FY2025, net income increased 37.2% year-over-year.
- Ranks #18 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +37.2% |
| FY2024 | $1.0B | +13.7% |
| FY2023 | $897.6M | +15.2% |
| FY2022 | $779.4M | +64.3% |
| FY2021 | $474.5M | -23.7% |
| FY2020 | $621.7M | +53.7% |
| FY2019 | $404.6M | +28.2% |
| FY2018 | $315.6M | -7.8% |
| FY2017 | $342.3M | -2.9% |
| FY2016 | $352.4M | -0.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026